Role of tenascin-C in articular cartilage

References

• Chiquet-Ehrismann R, Orend G, Chiquet M, Tucker RP, Midwood KS. Tenascins in stem cell niches. Matrix Biol. 2014;37:112–23.
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Tucker RP. Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol. 2011;3:a004960.
   PubMed Web of Science ®Google Scholar
• Chiquet M, Fambrough DM. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 1984;98:1926–36.
   PubMed Web of Science ®Google Scholar
• Chiquet M, Fambrough DM. Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol. 1984;98:1937–46.
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Höök M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol. 1991;115:1127–36.
   PubMed Web of Science ®Google Scholar
• Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, et al. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol. 2003;162:1857–67.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Akatsuka T, Imanaka-Yoshida K. Tenascin-C and integrins in cancer. Cell Adh Migr. 2015;9:96–104.
   PubMed Web of Science ®Google Scholar
• Giblin SP, Midwood KS. Tenascin-C: form versus function. Cell Adh Migr. 2015;9:48–82.
   PubMed Web of Science ®Google Scholar
• Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol. 1995;130:503–6.
   PubMed Web of Science ®Google Scholar
• Bornstein P. Matricellular proteins: an overview. J Cell Commun Signal. 2009;3:163–5.
   PubMed Web of Science ®Google Scholar
• Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009;41:771–83.
   PubMed Web of Science ®Google Scholar
• Bedore J, Leask A, Séguin CA. Targeting the extracellular matrix: matricellular proteins regulate cell-extracellular matrix communication within distinct niches of the intervertebral disc. Matrix Biol. 2014;37:124–30.
   PubMed Web of Science ®Google Scholar
• Halper J, Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol. 2014;802:31–47.
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell. 1988;53:383–90.
   PubMed Web of Science ®Google Scholar
• Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235–59.
   PubMed Web of Science ®Google Scholar
• Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo V, Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 2001;61:8586–94.
   PubMed Web of Science ®Google Scholar
• Midwood KS, Schwarzbauer JS. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol Biol Cell. 2002;13:3601–13.
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol. 2003;200:488–99.
   PubMed Web of Science ®Google Scholar
• Kreja L, Liedert A, Schlenker H, Brenner RE, Fiedler J, Friemert B, et al. Effects of mechanical strain on human mesenchymal stem cells and ligament fibroblasts in a textured poly(l-lactide) scaffold for ligament tissue engineering. J Mater Sci: Mater Med. 2012;23:2575–82.
   PubMed Web of Science ®Google Scholar
• Järvinen TA, Józsa L, Kannus P, Järvinen TL, Hurme T, Kvist M, et al. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci. 2003;116:857–66.
   PubMed Web of Science ®Google Scholar
• Mackey AL, Brandstetter S, Schjerling P, Bojsen-Moller J, Qvortrup K, Pedersen MM, et al. Sequences response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle. FASEB J. 2011;25:1943–59.
   PubMed Web of Science ®Google Scholar
• Flück M, Mund SI, Schittny JC, Klossner S, Durieux AC, Giraud MN. Mechano-regulated tenascin-C orchestrates muscle repair. Proc Natl Acad Sci USA. 2008;105:13662–7.
   PubMed Web of Science ®Google Scholar
• Kuettner KE, Aydelotte MB, Thonar EJ. Articular cartilage matrix and structure: a mini review. J Rheumatol. 1991;Suppl27:46–8.
   Google Scholar
• Tian J, Zhang FJ, Lei GH. Role of integrins and their ligands in osteoarthritic cartilage. Rheumatol Int. 2015;35:787–98.
   PubMed Web of Science ®Google Scholar
• Roughley PJ. Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage. Arthritis Res. 2001;3:342–7.
   PubMedGoogle Scholar
• Pacifici M, Iwamoto M, Golden EB, Leatherman JL, Lee YS, Chuong CM. Tenascin is associated with articular cartilage development. Dev Dyn. 1993;198:123–34.
   PubMed Web of Science ®Google Scholar
• Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 1987;105:2569–79.
   PubMed Web of Science ®Google Scholar
• Mackie EJ, Murphy LI. The role of tenascin-C and related glycoproteins in early chondrogenesis. Microsc Res Tech. 1988;43:102–10.
   Google Scholar
• Chevalier X, Groult N, Larget-Piet B, Zardi L, Hornebeck W. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1994;37:1013–22.
   PubMedGoogle Scholar
• Pfander D, Heinz N, Rothe P, Carl H, Swoboda B. Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis. Ann Rheum Dis. 2004;63:240–4.
   PubMed Web of Science ®Google Scholar
• Stein V, Li L, Lo G, Guermazi A, Zhang Y, Kent Kwoh C, et al. Pattern of joint damage in persons with knee osteoarthritis and concomitant ACL tears. Rheumatol Int. 2012;32:1197–208.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Felson DT. Osteoarthritis. BMJ. 2006;332:639–42.
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–501.
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 1993;36:181–9.
   PubMed Web of Science ®Google Scholar
• Clark AG, Jordan JM, Vilim V, Renner JB, Dragomir AD, Luta G, Kraus VB. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum. 1999;42:2356–64.
   PubMed Web of Science ®Google Scholar
• Rousseau JCh, Garnero P. Biological markers in osteoarthritis. Bone. 2012;51:265–77.
   PubMed Web of Science ®Google Scholar
• Mobasheri A, Bay-Jensen AC, van Spil WE, Larkin J, Levesque MC. Osteoarthritis year in review 2016: biomarkers (biochemical markers). Osteoarthr Cartil. 2017;25:199–208.
   PubMed Web of Science ®Google Scholar
• Patel L, Sun W, Glasson SS, Morris EA, Flannery CR, Chockalingam PS. Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord. 2011;12:164–77.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Hirata H, Sudo A, Kato K, Kawase D, Kinoshita N, et al. Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. J Rheumatol. 2004;31:2021–6.
   PubMed Web of Science ®Google Scholar
• Nakoshi Y, Hasegawa M, Sudo A, Yoshida T, Uchida A. Regulation of tenascin-C expression by tumor necrosis factor-alpha in cultured human osteoarthritis chondrocytes. J Rheumatol. 2008;35:147–52.
   PubMed Web of Science ®Google Scholar
• Chockalingam PS, Glasson SS, Lohmander LS. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation. Osteoarthritis Cartilage. 2013;21:339–45.
   PubMed Web of Science ®Google Scholar
• Nakoshi Y, Hasegawa M, Akeda K, Iino T, Sudo A, Yoshida T, Uchida A. Distribution and role of tenascin-C in human osteoarthritic cartilage. J Orthop Sci. 2010;15:666–73.
   PubMed Web of Science ®Google Scholar
• Spring J, Beck K, Chiquet-Ehrisman R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell. 1989;59:325–34.
   PubMed Web of Science ®Google Scholar
• Okamura N, Hasegawa M, Nakoshi Y, Iino T, Sudo A, Imanaka-Yoshida K, et al. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage. 2010;18:839–48.
   PubMed Web of Science ®Google Scholar
• Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem. 1995;270:8650–4.
   PubMed Web of Science ®Google Scholar
• Weber P, Zimmerman DR, Winterhalter KH, Vaughan L. Tenascin-C binds heparin by its fibronectin type III domain five. J Biol Chem. 1995;270:4619–23.
   PubMed Web of Science ®Google Scholar
• Day JM, Olin AI, Murdoch AD, Canfield A, Sasaki T, Timpl R, et al. Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem. 2004;279:12511–18.
   PubMed Web of Science ®Google Scholar
• Ikemura S, Hasegawa M, Iino T, Miyamoto K, Imanaka-Yoshida K, Yoshida T, Sudo A. Effect of tenascin-C on the repair of full-thickness osteochondral defects of articular cartilage in rabbits. J Orthop Res. 2015;33:563–71.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Hasegawa M, Iino T, Imanak-Yoshida K, Yoshida T, Sudo A. Tenascin-C prevents articular cartilage degeneration in murine osteoarthritis models. Cartilage. [Epub ahead of print]. doi: https://doi.org/10.1177/1947603516681134.
   Web of Science ®Google Scholar
• Sofat N, Robertson SD, Hermansson M, Jones J, Mitchell P, Wait R. Tenascin-C fragments are endogenous inducers of cartilage matrix degradation. Rheumatol Int. 2012;32:2809–17.
   PubMed Web of Science ®Google Scholar
• Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15:774–80.
   PubMed Web of Science ®Google Scholar
• van Lent PL, Blom AB, Grevers L, Sloetjes A, van den Berg WB. Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10. Ann Rheum Dis. 2007;66:334–40.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R. Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep. 2013;15:323.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Terkeltaub R. The growing array of innate inflammatory ignition switches in osteoarthritis. Arthritis Rheum. 2012;64:2055–8.
   PubMedGoogle Scholar
• Schmidt-Rohlfing B, Gavenis K, Kippels M, Schneider U. New potential markers for cartilage degradation of the knee joint. Scand J Rheumatol. 2002;31:151–7.
   PubMed Web of Science ®Google Scholar
• Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2004;43(Suppl3):iii2–9.
   Google Scholar
• Furst DE, Emery P. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford). 2014;53:1560–9.
   PubMed Web of Science ®Google Scholar
• Tani K, Shimizu T, Motoki Y, Sone S. Chemokines in synovial inflammation in rheumatoid arthritis: basic and clinical aspects. Mod Rheumatol. 2002;12:93–9.
   PubMedGoogle Scholar
• Miossec P, Verweij CL, Klareskog L, Pitzalis C, Barton A, Lekkerkerker F, et al. Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies. Ann Rheum Dis. 2011;70:1713–18.
   PubMed Web of Science ®Google Scholar
• Jilani AA, Mackworth-Young CG. The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol. 2015;2015:728610.
   PubMed Web of Science ®Google Scholar
• Piccinini AM, Midwood KS. Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep. 2012;2:914–26.
   PubMed Web of Science ®Google Scholar
• Imanaka-Yoshida K, Yoshida T, Miyagawa-Tomita S. Tenascin-C in development and disease of blood vessels. Anat Rec (Hoboken). 2014;297:1747–57.
   PubMedGoogle Scholar
• Page TH, Charles PJ, Piccinini AM, Nicolaidou V, Taylor PC, Midwood KS. Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther. 2012;14:R260.
   PubMedGoogle Scholar
• Hasegawa M, Nakoshi Y, Muraki M, Sudo A, Kinoshita N, Yoshida T, Uchida A. Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res. 2007;25:563–8.
   PubMed Web of Science ®Google Scholar
• Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, et al. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study. Arthritis Res Ther. 2015;17:341.
   PubMed Web of Science ®Google Scholar
• Schwenzer A, Jiang X, Mikuls TR, Payne JB, Sayles HR, Quirke AM, et al. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis. Ann Rheum Dis. 2016;75:1876–83.
   PubMed Web of Science ®Google Scholar